Evogene Ltd. (EVGN)
1.11
0.00 (0.00%)
USD |
NASDAQ |
Jan 09, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
Evogene Profit Margin (Quarterly): -874.7% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| MediWound Ltd. | -48.85% |
| Nano-X Imaging Ltd. | -397.0% |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -- |
| Nasus Pharma Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.95% |
| Return on Assets | -26.54% |
| Return on Invested Capital | -57.78% |
| Gross Profit Margin (Quarterly) | -40.38% |
| Operating Margin (Quarterly) | -870.2% |
| Return on Net Operating Assets | -64.10% |